';
The Office of Developmental Programs (ODP) has shared the announcement Additional Guidance for the End of Appendix K Flexibilities in the Consolidated, Community Living, Person/Family Directed Support (P/FDS) and Adult Autism Waivers. The purpose of the communication is to provide additional guidance on which Appendix K waiver flexibilities have been added to the approved intellectual disability/autism waivers (ID/A), which are the Consolidated, Community Living, and P/FDS Waivers, and the Adult Autism Waiver (AAW), as well as which Appendix K flexibilities will be ending November 11, 2023. You can view a quick guide for ID/A Waivers and a quick guide for the Adult Autism Waiver.
Please review all documents for additional information and details.
The Office of Developmental Programs (ODP) is providing information on the pending new annual submittal requirement of audited financial statements by qualified residential providers and supports coordination organizations. Please view the announcement for details.
The Office of Developmental Programs (ODP) has shared a list of current Agency With Choice (AWC) Financial Management Service (FMS) organizations that are available to support participants and surrogates who have chosen to self-direct some or all of their Participant Directed Services (PDS) using the AWC FMS model and are in the Consolidated, Community Living, or Person/Family Directed Support (P/FDS) waivers. Please view the announcement for additional information and to see the listing.
ODP Announcement 23-002 reports that the renewals for the Consolidated, Community Living, and Person/Family Directed Support (P/FDS) Waivers have been approved by the Centers for Medicare & Medicaid Services (CMS) with an effective date of January 1, 2023. CMS approves waivers for a five-year period. The current Consolidated, Community Living, and P/FDS Waivers expired June 30, 2022, but were extended twice as discussions continued between the Office of Developmental Programs (ODP) and CMS.
Major changes in the renewals include:
A list of all major changes made in the renewals is available in the record of change document and each full waiver application approved by CMS, which are available at:
ODP will be holding a webinar to discuss major changes made in these approved waiver renewals on February 9, 2023, from 1:00 pm – 2:00 pm. You can register for the webinar here.
Questions about this communication should be directed to the appropriate Office of Developmental Programs Regional Office.
ODP Bulletin 00-22-05, dated August 9, 2022, is to provide the Office of Developmental Programs’ (ODP) requirements and standardized processes for preparing, completing, documenting, implementing, and monitoring Individual Support Plans (ISPs) to ensure they are:
A summary of major changes made to information in the attachments is included as attachment 8.
ATTACHMENTS:
OBSOLETE DOCUMENTS:
ODP Announcement 22-084 informs all interested parties that the Office of Developmental Programs (ODP) is offering a webinar regarding the approved Consolidated, Community Living, and Person/Family Directed Support (P/FDS) waivers effective June 1, 2022. Information and the link to register for the webinar is as follows:
August 19, 2022
1:00 pm – 2:00 pm
Register here.
To access the current waivers that contain the changes that will be discussed during the webinar, please use the following links:
For each waiver, you will have the option to review the full waiver or the “Record of Change” document that contains a concise version of the substantial changes that were made.
CONTACT: Questions about this communication should be directed to the appropriate Office of Developmental Programs Regional Office.
ODP Announcement 22-061 is to announce that the amendments to the Consolidated, Community Living, and P/FDS waivers (hereafter referred to as the Intellectual Disability and Autism (ID/A) waivers) were approved by the Centers for Medicare & Medicaid Services (CMS) effective June 1, 2022.
The ID/A waiver amendments were submitted to CMS on January 3, 2022. Since that time, the Office of Developmental Programs (ODP) has been engaged in ongoing discussions with CMS. Substantive changes were approved as follows:
The following rates, as communicated in ODP Announcement 22-051, are also effective June 1, 2022, when authorized on an Individual Support Plan:
ODP will be scheduling webinars soon to discuss the changes made in these approved amendments, as well as changes made to the July 2022 waiver renewals once they are approved by CMS. ODP will release a communication announcing the webinars when the waiver renewals are approved. Questions about this communication should be directed to the appropriate Office of Developmental Programs Regional Office.
ODP Announcement 22-059 informs readers that the Office of Developmental Programs (ODP) is pleased to announce that an amendment to the AAW was submitted to CMS on May 9, 2022. The submitted AAW includes modifications that were made as a result of public comment. The AAW amendment includes the following substantive changes:
The requirements in the AAW will become effective when Appendix K flexibilities expire, six months after the expiration of the federal COVID-19 public health emergency.
Please note that aligning the Assistive Technology service, where possible, with the Consolidated, Community Living, and P/FDS waivers includes adding generators for the participant’s primary residence.
The full AAW application, as well as a record of substantive changes, is available here.
CMS has 90 days to review the amendment, and changes may occur to the content based upon discussion with CMS during the approval process. The proposed effective date of July 1, 2022, is also subject to change. ODP will inform all stakeholders when CMS has officially approved the AAW and will make the approved waiver available at that time.
Questions about this communication should be directed via email.
ODP Announcement 22-051 informs stakeholders that the following Fee Schedule Rates have been published as final in the Pennsylvania Bulletin:
Read the announcement for further details.